Matinas BioPharma (MTNB) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $2.42, -2.42% vs the prior close of $2.48.
- Volume 19.90K shares, 0.0x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
MTNB dips 2.4% to $2.42, 4 down days in a row. Closed at $2.42, -2.42% vs the prior close of $2.48. Day range $2.42–$2.54, opened at $2.44.
MTNB daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — MTNB dips 2.4% to $2.42, 4 down days in a row
- Closed at $2.42, -2.42% vs the prior close of $2.48. Day range $2.42–$2.54, opened at $2.44.
- Volume was 19.90K shares, 0.0x its 50-day average of 777.71K — lighter than usual.
- Price is +129.4% vs its 50-day average ($1.06) and +221.1% vs its 200-day average ($0.75).
- 52-week range $0.15–$6.60; today's close sits at 35% of that range, 63.3% below the 52-week high.
- That makes 4 straight losses.
Oct 14, 2026 — MTNB dips 0.8% to $2.48, 3 down days in a row
- Closed at $2.48, -0.80% vs the prior close of $2.50. Day range $2.45–$2.55, opened at $2.51.
- Volume was 19.80K shares, 0.0x its 50-day average of 797.77K — lighter than usual.
- Price is +126.7% vs its 50-day average ($1.09) and +233.0% vs its 200-day average ($0.74).
- 52-week range $0.15–$6.60; today's close sits at 36% of that range, 62.4% below the 52-week high.
- That makes 3 straight losses.
Oct 13, 2026 — MTNB slides 8.8% to $2.50
- Closed at $2.50, -8.76% vs the prior close of $2.74. Day range $2.46–$2.72, opened at $2.72.
- Volume was 66.40K shares, 0.1x its 50-day average of 840.37K — lighter than usual.
- Price is +138.0% vs its 50-day average ($1.05) and +239.8% vs its 200-day average ($0.74).
- 52-week range $0.15–$6.60; today's close sits at 36% of that range, 62.1% below the 52-week high.
Oct 12, 2026 — MTNB slides 4.5% to $2.74
- Closed at $2.74, -4.53% vs the prior close of $2.87. Day range $2.70–$2.85, opened at $2.85.
- Volume was 21.50K shares, 0.0x its 50-day average of 1.14M — lighter than usual.
- Price is +172.3% vs its 50-day average ($1.01) and +277.1% vs its 200-day average ($0.73).
- 52-week range $0.15–$6.60; today's close sits at 40% of that range, 58.5% below the 52-week high.
Oct 9, 2026 — MTNB rises 1.4% to $2.87
- Closed at $2.87, +1.41% vs the prior close of $2.83. Day range $2.70–$2.87, opened at $2.77.
- Volume was 35.30K shares, 0.0x its 50-day average of 1.17M — lighter than usual.
- Price is +199.6% vs its 50-day average ($0.96) and +300.4% vs its 200-day average ($0.72).
- 52-week range $0.15–$6.60; today's close sits at 42% of that range, 56.5% below the 52-week high.
Oct 8, 2026 — MTNB rises 2.2% to $2.83
- Closed at $2.83, +2.17% vs the prior close of $2.77. Day range $2.61–$2.85, opened at $2.73.
- Volume was 136.20K shares, 0.1x its 50-day average of 1.32M — lighter than usual.
- Price is +185.9% vs its 50-day average ($0.99) and +300.8% vs its 200-day average ($0.71).
- 52-week range $0.15–$6.60; today's close sits at 42% of that range, 57.1% below the 52-week high.
Oct 7, 2026 — MTNB slides 8.0% to $2.77
- Closed at $2.77, -7.97% vs the prior close of $3.01. Day range $2.63–$2.99, opened at $2.99.
- Volume was 170.50K shares, 0.0x its 50-day average of 5.44M — lighter than usual.
- Price is +195.0% vs its 50-day average ($0.94) and +298.1% vs its 200-day average ($0.70).
- 52-week range $0.15–$6.60; today's close sits at 41% of that range, 58.0% below the 52-week high.
Oct 6, 2026 — MTNB jumps 6.7% to $3.01, a 1-month high, 3 up days in a row
- Closed at $3.01, +6.74% vs the prior close of $2.82. Day range $2.64–$3.15, opened at $2.76.
- Volume was 417.70K shares, 0.1x its 50-day average of 6.11M — lighter than usual.
- Price is +238.1% vs its 50-day average ($0.89) and +339.1% vs its 200-day average ($0.69).
- 52-week range $0.15–$6.60; today's close sits at 44% of that range, 54.4% below the 52-week high.
- That makes 3 straight gains.
Oct 5, 2026 — MTNB jumps 6.8% to $2.82
- Closed at $2.82, +6.82% vs the prior close of $2.64. Day range $2.43–$3.00, opened at $2.78.
- Volume was 183.90K shares, 0.0x its 50-day average of 6.11M — lighter than usual.
- Price is +237.7% vs its 50-day average ($0.83) and +318.3% vs its 200-day average ($0.67).
- 52-week range $0.15–$6.60; today's close sits at 41% of that range, 57.3% below the 52-week high.
Oct 2, 2026 — MTNB jumps 9.1% to $2.64
- Closed at $2.64, +9.09% vs the prior close of $2.42. Day range $2.42–$2.75, opened at $2.53.
- Volume was 295.50K shares, 0.0x its 50-day average of 6.12M — lighter than usual.
- Price is +236.9% vs its 50-day average ($0.78) and +297.8% vs its 200-day average ($0.66).
- 52-week range $0.15–$6.60; today's close sits at 39% of that range, 60.0% below the 52-week high.
MTNB latest news & SEC filings
Every SEC filing by or about MTNB in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 28, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 3.03 — Change to shareholder rights.
- Item 5.03 — Amended its charter or bylaws / changed fiscal year.
Sep 16, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Sep 4, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 3.01 — Stock exchange listing notice or transfer of listing.
- Item 8.01 — Reported other events the company considers important.
Aug 13, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Net income: -$1.33M (prior year -$5.25M) (loss narrowed vs Jun 30, 2025)
- Diluted EPS: -$0.21 (prior year -$1.03) (loss narrowed vs Jun 30, 2025)
Aug 13, 2026 · Form SCHEDULE 13D/A — Update to a 13D 5%+ stake disclosure
Update to a 13D 5%+ stake disclosure
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 13, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 13, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 24, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.02 — Ended a material agreement.
Jul 14, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Things to know before you trade MTNB
- Last results release: Aug 14, 2024 (8-K Item 2.02). Previous ones: May 9, 2024, Mar 27, 2024, Nov 8, 2023. Based on that rhythm, the next report is likely around Nov 13, 2024 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 89.69% (largest 1700.0%). That is a volatile stock.
- Liquidity: about 266.00K shares (≈$643.72K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $2.42 vs a range of $0.15–$6.60 (35% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: 1:15 on Sep 28, 2026
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 8-K Sep 28, 2026; 8-K Sep 16, 2026; 8-K Sep 4, 2026.
- Share count: 14.69M shares outstanding (Aug 10, 2026), +188.8% vs a year earlier — notable dilution.
- Listing: NYSE · industry: Pharmaceutical Preparations.
MTNB market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 2.44 | 2.54 | 2.42 | 2.42 | 19.90K |
| Oct 14, 2026 | 2.51 | 2.55 | 2.45 | 2.48 | 19.80K |
| Oct 13, 2026 | 2.72 | 2.72 | 2.46 | 2.50 | 66.40K |
| Oct 12, 2026 | 2.85 | 2.85 | 2.70 | 2.74 | 21.50K |
| Oct 9, 2026 | 2.77 | 2.87 | 2.70 | 2.87 | 35.30K |
| Oct 8, 2026 | 2.73 | 2.85 | 2.61 | 2.83 | 136.20K |
| Oct 7, 2026 | 2.99 | 2.99 | 2.63 | 2.77 | 170.50K |
| Oct 6, 2026 | 2.76 | 3.15 | 2.64 | 3.01 | 417.70K |
| Oct 5, 2026 | 2.78 | 3.00 | 2.43 | 2.82 | 183.90K |
| Oct 2, 2026 | 2.53 | 2.75 | 2.42 | 2.64 | 295.50K |
| Oct 1, 2026 | 2.58 | 2.58 | 2.36 | 2.42 | 43.80K |
| Sep 30, 2026 | 2.72 | 2.80 | 2.44 | 2.55 | 152.50K |
| Sep 29, 2026 | 2.47 | 3.05 | 2.40 | 2.88 | 757.50K |
| Sep 25, 2026 | 0.17 | 0.18 | 0.15 | 0.16 | 760.70K |
| Sep 24, 2026 | 0.17 | 0.18 | 0.17 | 0.18 | 231.00K |
| Sep 23, 2026 | 0.18 | 0.18 | 0.17 | 0.17 | 418.60K |
| Sep 22, 2026 | 0.17 | 0.18 | 0.17 | 0.18 | 197.70K |
| Sep 21, 2026 | 0.16 | 0.17 | 0.16 | 0.17 | 292.10K |
| Sep 18, 2026 | 0.16 | 0.17 | 0.16 | 0.16 | 425.90K |
| Sep 17, 2026 | 0.16 | 0.16 | 0.16 | 0.16 | 673.50K |
About Matinas BioPharma
Matinas BioPharma (MTNB) is listed on the NYSE and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in BEDMINSTER, NJ. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1582554.
MTNB board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| No Form 3/4/5 filings by this group in the last 12 months. | ||
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| No Form 3/4/5 filings by this group in the last 12 months. | ||
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
MTNB financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | — | $-10.35M | -2.00 | $-7.01M |
| Dec 31, 2024 | — | $-24.25M | -4.98 | $-15.88M |
| Dec 31, 2023 | $1.10M | $-22.94M | -5.28 | $-15.28M |
| Dec 31, 2022 | $3.19M | $-21.00M | -0.10 | $-19.16M |
| Dec 31, 2021 | $33.00K | $-23.28M | — | $-15.22M |
Latest balance sheet: total assets $3.41M, total liabilities $1.61M, cash $761.00K (as of Jun 30, 2026).
MTNB earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 14, 2024 | 8-K Item 2.02 (results) | — |
| May 9, 2024 | 8-K Item 2.02 (results) | — |
| Mar 27, 2024 | 8-K Item 2.02 (results) | — |
| Nov 8, 2023 | 8-K Item 2.02 (results) | — |
| Aug 9, 2023 | 8-K Item 2.02 (results) | — |
| May 10, 2023 | 8-K Item 2.02 (results) | — |
| Mar 15, 2023 | 8-K Item 2.02 (results) | — |
| Nov 2, 2022 | 8-K Item 2.02 (results) | — |
| Aug 11, 2022 | 8-K Item 2.02 (results) | — |
| May 12, 2022 | 8-K Item 2.02 (results) | — |
| Mar 8, 2022 | 8-K Item 2.02 (results) | — |
| Nov 8, 2021 | 8-K Item 2.02 (results) | — |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)AbbVie (ABBV)Merck (MRK)Abbott Laboratories (ABT)Vertex Pharmaceuticals Inc / Ma (VRTX)Pfizer (PFE)Bristol Myers Squibb (BMY)Astrazeneca (AZN)Regeneron Pharmaceuticals (REGN)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on MTNB
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.